15 records – page 1 of 1.

CMA's Submission to the Senate Committee on Social Affairs, Science and Technology as part of its study on prescription pharmaceuticals: federal levers to address unintended consequences of prescription pharmaceuticals and support public health, quality care, and patient safety

Date
2014-03-26
Topics
Pharmaceuticals, prescribing, cannabis, drugs
. 2) Addressing the misuse and abuse of prescription medication The use of prescription opioid pain relievers is on the rise, in Canada and internationally. Latest reports indicate that Canada has the second highest per capita consumption of prescription opioids in the world, after the United

CMA submission to the study of Bill C-37

Date
2017-04-06
Topics
Pharmaceuticals, prescribing, cannabis, drugs

Consultation on the prescription drug list: Naloxone

Date
2016-03-19
Topics
Pharmaceuticals, prescribing, cannabis, drugs
settings”. The CMA has over 83,000 physician-members. Its mission is helping physicians care for patients and its vision is to be the leader in engaging and serving physicians, and the national voice for the highest standards for health and health care. The harms associated with opioids, which

Harms associated with opioids and other psychoactive prescription drugs

Date
2015-05-30
Topics
Pharmaceuticals, prescribing, cannabis, drugs
the Member Service Centre, Canadian Medical Association, 1867 Alta Vista Drive, Ottawa, ON K1G 5W8; tel 888 855-2555 or 613 731-8610 x2307; fax 613 236-8864. All polices of the CMA are available electronically through CMA Online (www.cma.ca). CMA POLICY HARMS ASSOCIATED WITH OPIOIDS AND

Health Canada consultation on Canadian drugs and substances strategy

Date
2018-12-04
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Population health, health equity, public health
Policy makers must recognize that prescription opioids are an essential tool in the alleviation of pain and suffering, particularly in palliative and cancer care.7 Doctors support patients in the management of acute and chronic pain, as well as problematic substance use, and as such have long been

Health Canada consultation on regulatory amendments regarding tramadol

Date
2018-08-14
Topics
Pharmaceuticals, prescribing, cannabis, drugs
being judged low-risk in terms of addiction, it is nevertheless an opioid and should be placed in the Controlled Drugs and Substances Act, under Schedule 1.2 The Canadian Institute for Health Information reports that tramadol is one of six opioids accounting for 96% of all opioid prescriptions

Health Canada consultation on restriction of marketing and advertising of opioids

Date
2018-07-18
Topics
Pharmaceuticals, prescribing, cannabis, drugs
CMA response: HEALTH CANADA CONSULTATION ON RESTRICTION OF MARKETING AND ADVERTISING OF OPIOIDS July 18, 2018 The Canadian Medical Association

The need for a national strategy to address abuse and misuse of prescription drugs in Canada: Canadian Medical Association submission to the House of Commons Standing Committee on Health

Date
2013-11-27
Topics
Pharmaceuticals, prescribing, cannabis, drugs
, notably opioids such as oxycodone, fentanyl and hydromorphone, is emerging as a significant public health and safety issue. The use of prescription opioids is on the rise, in Canada and internationally. Canada has the second highest per capita consumption of prescription opioids in the world

Non-prescription availability of low-dose codeine products

Date
2017-11-7
Topics
Pharmaceuticals, prescribing, cannabis, drugs
. Available: https://www.cma.ca/Assets/assets- library/document/en/advocacy/submissions/hesa-opioid-study-opening-remarks-oct-18-2016-e.pdf (accessed: 2017 Nov 7). 14 Canadian Medical Association. Harms Associated with Opioids and Other Psychoactive Prescription Drugs. CMA Policy, 2015. Ottawa: The

Open letter to Ontario Minister of Health about the newly proposed “Consumption and Treatment Services” model

Date
2018-10-31
Topics
Population health, health equity, public health

Proposed amendments to the marihuana for medical purposes regulations

Date
2014-07-11
Topics
Pharmaceuticals, prescribing, cannabis, drugs
potential for harm to patients and the possibility for misuse or abuse of medications, particularly opioids and other such substances. For these reasons, the CMA advocates for an inter-operable, pan-Canadian system of real-time prescription monitoring and surveillance for controlled substances

Review of Controlled Drugs and Substances Act: Canadian Medical Association submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations

Date
2014-03-17
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Prescription Drug Misuse and Abuse The misuse and abuse of controlled psychoactive prescription medicines, notably opioids such as oxycodone, fentanyl and hydrocodone, is a significant public health and patient safety issue. Canada has the second highest per capita consumption of prescription opioids

Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada

Date
2016-10-18
Topics
Pharmaceuticals, prescribing, cannabis, drugs
Population health, health equity, public health
Health care and patient safety
crisis related to problematic opioid and fentanyl use. Physicians are on the front lines in many respects. Doctors are responsible for supporting patients with the management of acute and chronic pain. Policy makers must recognize that prescription opioids are an essential tool in the alleviation

Support life-saving supervised consumption and overdose prevention sites: Open letter to Premier Doug Ford and Health Minister Christine Elliott

Date
2018-08-30
Topics
Pharmaceuticals, prescribing, cannabis, drugs
and other necessary health services; and • benefit public order by reducing public injecting.3 As you know,Canada is experiencing a large-scale opioid overdose crisis. In Ontario alone, overdose deaths related to opioids increased by 45 per cent in 2017, with more than three people dying every

Tamper resistance under the Controlled Drugs and Substances Act

Date
2014-08-26
Topics
Health care and patient safety
Pharmaceuticals, prescribing, cannabis, drugs
, there was a rise in the use of heroin and other opioids which did not have abuse deterrent technology 8, 9 . Tamper-resistant technologies have not been proven to be 100% effective in preventing abuse. They are not successful in preventing the most common form of abuse, which is the ingestion

15 records – page 1 of 1.